Sunday, November 10, 2019

Sobi Successfully Completes Tender Offer for All Outstanding Shares of Dova Pharmaceuticals

STOCKHOLM, Nov. 10, 2019 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: SOBI) announced today that its indirect wholly owned subsidiary Dragonfly Acquisition Corp. (Dragonfly) has successfully completed its tender offer to purchase all outstanding shares of Dova...



from PR Newswire: https://ift.tt/2NAe976

No comments:

Post a Comment